@article{TLCR22698,
author = {Glen J. Weiss},
title = {A new era of treating advanced lung cancer is upon us},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 3},
year = {2018},
keywords = {},
abstract = {From the adaption of chemotherapy in the 1990’s after the landmark meta-analysis (1) to the pivotal randomized trial pointing to “dealer’s choice” for platinum-doublet regimens (2), followed by treatment refinement using molecular profiling and targeted therapy for defined sub-populations (3,4), we now have the emergence of a new era to treat advanced non-small cell lung cancer (NSCLC).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/22698}
}